Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

327.000
+12.0003.81%
Volume:505.41K
Turnover:166.03M
Market Cap:29.48B
PE:-2.49
High:338.800
Open:317.000
Low:317.000
Close:315.000
52wk High:563.500
52wk Low:165.500
Shares:90.14M
HK Float Shares:90.14M
Volume Ratio:0.90
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-131.304
ROE:--
ROA:-6.51%
PB:8.96
PE(LYR):-2.49
PS:12.02

Loading ...

Hong Kong Stock Market Movement | DUALITYBIO-B (09606) Surges Over 6%, Company's 2026 Clinical Data Expected for Dense Readout

Stock News
·
Jan 27

Hong Kong Stock Movement | DUALITYBIO-B (09606) Rises Over 4% in Morning Session as ADAM9-Targeting ADC Cancer Drug Approved for Clinical Trials in China

Stock News
·
Jan 20

Duality Biotherapeutics Executive Director of Human Resources & Executive Director Wen Si Sells 100% Of Holding

Simply Wall St.
·
Jan 20

Hong Kong Stock Movement | DUALITYBIO-B (09606) Surges Over 12% on Rich 2026 Catalysts; Institution Raises Target Price

Stock News
·
Jan 05

GTHT Raises DUALITYBIO-B (09606) Target Price to HK$455.56, Maintains Add Rating

Stock News
·
Jan 05

Duality Biotherapeutics Inc. held extraordinary general meeting

Reuters
·
Dec 30, 2025

Hong Kong Stocks Movement | DUALITYBIO-B (09606) Rises Over 3% in Early Trading as DB-1310 Receives FDA Fast Track Designation

Stock News
·
Dec 19, 2025

DUALITYBIO-B (09606) Proposes Adoption of 2025 Share Scheme

Stock News
·
Dec 14, 2025

Duality Biotherapeutics Inc. Proposes 2025 Share Scheme for Shareholder Approval at Upcoming EGM

Reuters
·
Dec 14, 2025

HK Stock Connect Shareholding Changes | December 8

Stock News
·
Dec 08, 2025

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress
·
Dec 04, 2025

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress
·
Dec 03, 2025

Are Investors Undervaluing Duality Biotherapeutics, Inc. (HKG:9606) By 49%?

Simply Wall St.
·
Dec 02, 2025

Southbound Capital Flow Data (T+2) for Dec 2

Stock News
·
Dec 02, 2025

CISI FIN Initiates Coverage on DUALITYBIO-B (09606) with "Overweight" Rating, Highlights Leadership in Next-Gen ADC Innovation

Stock News
·
Nov 28, 2025

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress
·
Nov 26, 2025

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24, 2025

HK Stock Connect Holdings Change Report | Nov 20

Stock News
·
Nov 20, 2025

Analysis of Hong Kong Stock Connect Holdings as of November 19

Stock News
·
Nov 19, 2025

HK Stock Movement | DUALITYBIO-B (09606) Rises Over 8% Again as DB-1418 Granted FDA Fast Track Designation and Approved for Clinical Trials in China

Stock News
·
Nov 13, 2025